In addition, The inhibition of neointimal hyperplasia by a TRPC1 specific antibody (T1E3) further supports the involvement of TRPC1 in the pathogenesis of vascular obstructive diseases, such as atherosclerosis (Kumar et al., 2006). Here, TRPC1 is linked to atherosclerosis.